These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33292815)

  • 1. Comparing quality of reporting between preprints and peer-reviewed articles in the biomedical literature.
    Carneiro CFD; Queiroz VGS; Moulin TC; Carvalho CAM; Haas CB; Rayêe D; Henshall DE; De-Souza EA; Amorim FE; Boos FZ; Guercio GD; Costa IR; Hajdu KL; van Egmond L; Modrák M; Tan PB; Abdill RJ; Burgess SJ; Guerra SFS; Bortoluzzi VT; Amaral OB
    Res Integr Peer Rev; 2020 Dec; 5(1):16. PubMed ID: 33292815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and Reach of Orthopaedic Research Posted to Preprint Servers: Are We "Undercooking" Our Science?
    Rizk AA; Arza RA; Jella TK; Cwalina TB; Sanghvi PA; Hadad MJ; Pumo TJ; Kamath AF
    Clin Orthop Relat Res; 2023 Aug; 481(8):1491-1500. PubMed ID: 36897188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Clinical Study Results Reported in medRxiv Preprints vs Peer-reviewed Journal Articles.
    Janda G; Khetpal V; Shi X; Ross JS; Wallach JD
    JAMA Netw Open; 2022 Dec; 5(12):e2245847. PubMed ID: 36484989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Preprint Postings of Randomized Clinical Trials on COVID-19 and Corresponding Published Journal Articles: A Systematic Review.
    Bai AD; Jiang Y; Nguyen DL; Lo CKL; Stefanova I; Guo K; Wang F; Zhang C; Sayeau K; Garg A; Loeb M
    JAMA Netw Open; 2023 Jan; 6(1):e2253301. PubMed ID: 36705921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transparency and reporting characteristics of COVID-19 randomized controlled trials.
    Kapp P; Esmail L; Ghosn L; Ravaud P; Boutron I
    BMC Med; 2022 Sep; 20(1):363. PubMed ID: 36154932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Publication and Impact of Preprints Included in the First 100 Editions of the CDC COVID-19 Science Update: Content Analysis.
    Otridge J; Ogden CL; Bernstein KT; Knuth M; Fishman J; Brooks JT
    JMIR Public Health Surveill; 2022 Jul; 8(7):e35276. PubMed ID: 35544426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Publication rate and citation counts for preprints released during the COVID-19 pandemic: the good, the bad and the ugly.
    Añazco D; Nicolalde B; Espinosa I; Camacho J; Mushtaq M; Gimenez J; Teran E
    PeerJ; 2021; 9():e10927. PubMed ID: 33717688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining linguistic shifts between preprints and publications.
    Nicholson DN; Rubinetti V; Hu D; Thielk M; Hunter LE; Greene CS
    PLoS Biol; 2022 Feb; 20(2):e3001470. PubMed ID: 35104289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Publishing of COVID-19 preprints in peer-reviewed journals, preprinting trends, public discussion and quality issues.
    Kodvanj I; Homolak J; Virag D; Trkulja V
    Scientometrics; 2022; 127(3):1339-1352. PubMed ID: 35125557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of citations of medRxiv preprints in articles published on COVID-19 in the world leading medical journals.
    Gehanno JF; Grosjean J; Darmoni SJ; Rollin L
    PLoS One; 2022; 17(8):e0264661. PubMed ID: 35947594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Releasing a preprint is associated with more attention and citations for the peer-reviewed article.
    Fu DY; Hughey JJ
    Elife; 2019 Dec; 8():. PubMed ID: 31808742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic analysis of preprints in Trauma & Orthopaedic surgery.
    Hodel S; Selman F; Mania S; Maurer SM; Laux CJ; Farshad M
    Bone Jt Open; 2022 Aug; 3(8):582-588. PubMed ID: 35848996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracking the popularity and outcomes of all bioRxiv preprints.
    Abdill RJ; Blekhman R
    Elife; 2019 Apr; 8():. PubMed ID: 31017570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of academic publications, preprints, and registered clinical trials on the COVID-19 pandemic.
    Gianola S; Jesus TS; Bargeri S; Castellini G
    PLoS One; 2020; 15(10):e0240123. PubMed ID: 33022014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PreprintMatch: A tool for preprint to publication detection shows global inequities in scientific publication.
    Eckmann P; Bandrowski A
    PLoS One; 2023; 18(3):e0281659. PubMed ID: 36888577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motivations, concerns and selection biases when posting preprints: A survey of bioRxiv authors.
    Fraser N; Mayr P; Peters I
    PLoS One; 2022; 17(11):e0274441. PubMed ID: 36327267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting of funding and conflicts of interest improved from preprints to peer-reviewed publications of biomedical research.
    Itani D; Lababidi G; Itani R; El Ghoul T; Hamade L; Hijazi ARA; Khabsa J; Akl EA
    J Clin Epidemiol; 2022 Sep; 149():146-153. PubMed ID: 35738307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjusting the use of preprints to accommodate the 'quality' factor in response to COVID-19.
    Teixeira da Silva JA
    J Taibah Univ Med Sci; 2021 Aug; 16(4):477-481. PubMed ID: 34408603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of single comments left for bioRxiv preprints till September 2019.
    Malički M; Costello J; Alperin JP; Maggio LA
    Biochem Med (Zagreb); 2021 Jun; 31(2):020201. PubMed ID: 33927548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of effect estimates between preprints and peer-reviewed journal articles of COVID-19 trials.
    Davidson M; Evrenoglou T; Graña C; Chaimani A; Boutron I
    BMC Med Res Methodol; 2024 Jan; 24(1):9. PubMed ID: 38212714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.